As of 2026-05-28, the Relative Valuation of Hangzhou Tigermed Consulting Co Ltd (300347.SZ) is 35.11 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 39.70 CNY, the upside of Hangzhou Tigermed Consulting Co Ltd based on Relative Valuation is -11.6%.
The range of the Relative Valuation is 18.65 - 52.43 CNY.
| Range | Selected | |
| Trailing P/E multiples | 20.8x - 47.7x | 35.8x |
| Forward P/E multiples | 24.2x - 38.7x | 28.2x |
| Fair Price | 18.65 - 52.43 | 35.11 |
| Upside | -53.0% - 32.1% | -11.6% |
| Date | P/E |
| 2026-05-25 | 47.21 |
| 2026-05-22 | 47.23 |
| 2026-05-21 | 50.75 |
| 2026-05-20 | 50.10 |
| 2026-05-19 | 50.91 |
| 2026-05-18 | 51.46 |
| 2026-05-15 | 52.19 |
| 2026-05-14 | 53.53 |
| 2026-05-13 | 54.79 |
| 2026-05-12 | 57.51 |
| 2026-05-11 | 58.48 |
| 2026-05-08 | 57.10 |
| 2026-05-07 | 59.30 |
| 2026-05-06 | 60.25 |
| 2026-04-30 | 61.61 |
| 2026-04-29 | 62.93 |
| 2026-04-28 | 65.17 |
| 2026-04-27 | 63.46 |
| 2026-04-24 | 62.52 |
| 2026-04-23 | 62.62 |
| 2026-04-22 | 64.05 |
| 2026-04-21 | 63.82 |
| 2026-04-20 | 65.48 |
| 2026-04-17 | 64.29 |
| 2026-04-16 | 65.43 |
| 2026-04-15 | 65.91 |
| 2026-04-14 | 66.35 |
| 2026-04-13 | 62.57 |
| 2026-04-10 | 64.58 |
| 2026-04-09 | 62.28 |
| 2026-04-08 | 62.55 |
| 2026-04-07 | 61.87 |
| 2026-04-03 | 61.72 |
| 2026-04-02 | 62.84 |
| 2026-04-01 | 63.67 |
| 2026-03-31 | 60.08 |
| 2026-03-30 | 58.80 |
| 2026-03-27 | 59.66 |
| 2026-03-26 | 56.68 |
| 2026-03-25 | 56.34 |
| 2026-03-24 | 54.47 |
| 2026-03-23 | 53.06 |
| 2026-03-20 | 56.04 |
| 2026-03-19 | 57.11 |
| 2026-03-18 | 59.14 |
| 2026-03-17 | 59.10 |
| 2026-03-16 | 60.65 |
| 2026-03-13 | 61.51 |
| 2026-03-12 | 62.29 |
| 2026-03-11 | 63.12 |